BIO-RAD LABORATORIES, INC. — Director's Dealing 2022

Sep 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2022-09-01

Reporting Person: Daskal Ilan (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-01	Bio-Rad A Common Stock	M	455	—	Acquired	907	Direct
2022-09-01	Bio-Rad A Common Stock	F	226	$486.25	Disposed	681	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-01	Restricted Stock Units	$0	A	2776	Acquired		Bio-Rad A Common Stock (2776)	Direct
2022-09-01	Restricted Stock Units	$0	M	455	Disposed		Bio-Rad A Common Stock (455)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

F4: On September 1, 2021, the reporting person was granted 1,823 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.